APPLICATIONS PUBLISHED 29 OCTOBER 2003
Published: 1-Apr-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Block-structure copolymer consisting of a saccharide segment bound to at least a biodegradable hydrophobic segment, and corresponding particles
Centre National de la Recherche Scientifique 1355627*
Stabilised polymeric aerosols for pulmonary gene delivery
Board of Regents, the University of Texas System 1355628*
Solid phase dispersion of quinolone- or naphthyridonecarboxylic acids
Bayer Healthcare 1355629*
Method of forming microparticles
The Board of Trustees of the University of Illinois 1355630*
Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
Pharmacia 1355631*
Amlopidine free base
Pfizer 1355632*
New film coating
AstraZeneca 1355633*
SN-38 lipid complexes and methods of use
Neopharm 1355634*
New film coating
AstraZeneca 1355635*
Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method of production of the same
LTS Lohmann Therapie-System 1355636*
Inhibitors of matripase for the treatment of cancer
Georgetown University Medical Centre 1355637*
Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
Magnesium Diagnostics 1355638*
Substituted carbostyril derivatives as 5-HT1A receptor subtype agonists
Otsuka Pharmaceuticals 1355639*
Use of non-competitive and selective GLUR5 antagonists as glutamate receptor modulating compounds
Neurosearch 1355640*
Use of (R)-ibuprofen methanesulphonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs
Dompe 1355641*
Inhibition of NF-(K)B by triterpene compsns
Research Development Foundation 1355642*
Epoxyvibsanin B
Shionogi Bioresearch Corporation 1355643*
The use of substituted azetidinone compounds for the treatment of sitosterolemia
Schering 1355644*
Method for treating fibrotic diseases or other indications IIIC
Alteon 1355645*
Muscarinic receptor agonists
University of Toledo 1355646*
The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers
RT Alamo Ventures 1355647*
1,2-disubstituted cyclic inhibitors of matrix metalloproteases and TNF-[a]
Bristol-Myers Squibb Pharma 1355648*
Pharmaceutical formulation containing pyrazolo [ 4,3-] pyrimidine and nitrates or thienopyrimidines
Merck Patent 1355649*
New combination of active ingredients containing alfuzosine and apomorphine
Sanofi-Synthelabo 1355650*
Treatment of diabetes mellitus using vardenafil
Pfizer 1355651*
Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
Inspire Pharmaceuticals 1355652*
Stimulation of thymus for vaccination development
Monash University 1355653*
Lower alcohol-insoluble extract of Hovenia dulcis var. Koreana nakai, a polysaccharide isolated therefrom and a antihepatotoxic compsn containing same
Lifetree Biotech; Forestry Research Institute 1355654*
Compsns and methods for improving kidney function
ZymoGenetics 1355655*
Red blood cells as vehicle for agent-membrane translocation sequence conjugate
Gendel 1355656*
GSSP3 polynucleotides and polypeptides and uses thereof
Genset 1355657*
PYK2 phosphorylation by HER3 induces tumour invasion
Max-Planck-Gesellschaft zur Foerderung der Wissenschaften 1355658*
Use of compsns containing PDGF-BB for promoting angiogenesis
Genetix Pharmaceuticals 1355659*
Therapeutic modulation of the tumour inflammatory response
Biother Corporation 1355660*
Tumour vaccine
Mologen Forschungs-, Entwicklungs- und Vertriebs 1355661*
Method of preventing T cell mediated responses by the use of the major histocompatibility complex class II analogue protein (MAP protein) from Staphylococcus aureus
The Texas A&M University System 1355662*
Method for treating an HIV-infected individual by combining immunisation with structured interruption of anti-retroviral treatment
The Immune Response Corp 1355663*
Methods employing and compsns containing plaque associated molecules for prevention and treatment of atherosclerosis
Vascular Biogenics 1355664*
Treatment of juvenile rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
Weisbart, Richard; Barstow, Leon 1355665*
Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
Crucell Holland 1355667*
Use of IL-18 inhibitors for the treatment and prevention of heart disease
Applied Research Systems 1355668*
Augmented cognitive training
Cold Spring Harbour Laboratory 1355669*
Enhanced stabilised plasma-lipid particle-mediated transfection using endosomal membrane destabilisers
University of British Columbia 1355670*
Water-soluble polymer conjugates of triazine derivatives
Nektar Therapeutics AI; Cornerstone Pharmaceuticals 1355671*
Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compsns and methods of use
Cell Works; Johns Hopkins University 1355672*
Multivalent meningococcal polysaccharide-protein conjugate vaccine
Aventis Pasteur 1355673*
Oligo or polyalkylene glycol-coupled thrombin inhibitors
HaemoSys 1355674*
Anti-tumour compounds
Universite Catholique de Louvain 1355675*
Protecting therapeutic compsns from host-mediated inactivation
University of South Carolina Research Foundation 1355676*
Thiazolamines and their use as TGF-β inhibitors
Glaxo Group 1355870*
Process for the purification of 1,3-diketones
Roche Vitamins 1355871*
Process for the stereoselective synthesis of prostacyclin derivatives
United Therapeutics Corp 1355872*
Pleuromutilin derivatives with antimicrobial activity
SmithKline Beecham 1355873*
Process for the synthesis of mixtures of methane diphenyl diamine and its higher homologues with a controlled isomer distribution
Dow Global Technologies 1355874*
3,4-disubstituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
Schering; Pharmacopeia 1355875*
Methods of chemical synthesis of phenolic nitrogen mustard prodrugs
Cancer Research Technology 1355876*
Process of obtaining compsns of stable lutein and lutein derivatives
Sabinsa Corp 1355877*
Antipicornaviral compounds and compsns, their pharmaceutical uses, and materials for their synthesis
Agouron Pharmaceuticals 1355878*
Carboxamides as fungicides in agriculture
Syngenta Participations 1355879*
Process for the preparation of heterocyclic indene analogues
F Hoffmann-La Roche 1355880*
An improved process for preparing pure ondansetron hydrochloride dihydrate
Teva Pharmaceutical Industries 1355881*
Chiral scaffolds and their preparation
Chirotech Technology 1355882*
Novel multidentate sulphur-containing ligands
The University of Kentucky Research Foundation 1355883*
Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
Pfizer Products 1355884*
Pyridine derivatives useful as cyclooxygenase inhibitor
Fujisawa Pharmaceuticals 1355885*
Fused heterocyclic compounds
Takeda Chemical Industries 1355886*
Pyrimidine acyclonucleoside derivatives, preparation method and use thereof
Universite de Geneve 1355887*
Quinazolinone derivatives
Fujisawa Pharmaceuticals 1355888*
Substituted triazole diamine derivatives as kinase inhibitors
Ortho-McNeil Pharmaceutical 1355889*
1m2m4-oxadiazole derivatives as HP-PAR alpha agonists
Glaxo Group 1355890*
Therapy
AstraZeneca 1355891*
2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (TGF-β) inhibitors
Glaxo Group 1355892*
Antiangiogenic compounds and an assay for inhibitors of cell invasion
The University of British Columbia 1355893*
Amidinophenylalanine derivatives as thrombin inhibitors
Univerza V Ljubljani, Fakulteta za Farnacijo; Lek Pharmaceutical and Chemical 1355894*
Compounds for pest control
The Government of the United States, as represented by the Secretary, Department of Health and Human Services, Center for Disease Control and Prevention 1355895*
Method for producing epoxidated glyceride acetates
Cognis Deutschland 1355896*
Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
Orion Corp Fermion 1355897*
Method for producing flavone derivatives
Merck 1355898*
Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
Pfizer Products 1355899*
Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands
Wyeth 1355900*
1,1-disubstituted cyclic inhibitors of matrix metalloprotease and TNF-α
Bristol-Myers Squibb 1355901*
Sulphonamide compounds, their preparation and use
SmithKline Beecham 1355902*
Pyrazole compounds against TGF overexpression
Glaxo Group 1355903*
Heterocyclindazole and azaindole compounds and 5-hydroxytryptamine-6 ligands
Wyeth 1355904*
Pyrazole compounds useful as protein kinase inhibitors
Vertex Pharmaceuticals 1355905*
2H-1 benzopyran derivatives, processes for the preparation and pharmaceutical compsns thereof
Chiesi Farmaceutici 1355906*
Thiazolyl-, oxazolyl-, pyrrolyl, and -imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
Pfizer 1355907*
New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method of obtaining them
Laboratorios Vita 1355908*
Dihydropyrazolopyridine compounds and pharmaceutical use thereof
Mitsubishi Pharma 1355909*
Formation of boronic acid compounds
The United States of America, as represented by the Secretary, Department of Health and Human Services, National Institutes of Health 1355910*
Nanosized copper catalyst precursors for the direct synthesis of trialkoxysilanes
Crompton Corp 1355911*
Ligands and their use
Chirotech Technology 1355912*
Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same
Lee, Seung-Yong 1355913*
Preparation of aliphatic acid ester of carbohydrate
Jo, In-Ho 1355914*
Labelling compounds for the simple synthesis of 3'(18F)fluoro-3'-deoxy thymidine and a method for the production thereof
Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts 1355915*
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
Merck; Isis Pharmaceuticals 1355916*
Compsns and methods relating to breast specific genes and proteins
Diadexus 1355917*
Recombinant protective protein from Streptococcus pneumoniae
Wyeth 1355918*
Molecules with extended half-lives, compsns and uses thereof
Medimmune 1355919*
Extractive purification of lipopeptide antibiotics
Micrologix Biotech 1355920*
Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
North Shore-Long Island Jewish Health System 1355921*
Stress proteins and peptides and methods of use thereof
The Regents of the University of California San Diego 1355922*
Immunomodulatory peptides derived from heat shock proteins and uses thereof
The Regents of the University of California 1355923*
Armed peptides
Anmat Technology 1355924*
Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
Academisch Ziekenhuis Leiden 1355925*
Therapeutic compounds for ovarian cancer
Genzyme 1355926*
